FIELD: chemistry.
SUBSTANCE: invention relates to a conjugate of an anti-TROP-2 antibody and an exatecan analogue and its medical use. Presented is a conjugate of an anti-TROP-2 antibody and an exatecan analogue of general formula (Pc-L-Y-D), where Pc is an anti-TROP-2 antibody or an antigen-binding fragment thereof.
EFFECT: greater tumor efficacy.
35 cl, 5 dwg, 9 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATE OF ANTI-CLAUDIN ANTIBODY AND MEDICINAL AGENT AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2826119C1 |
| ERIBULIN DERIVATIVE DRUG CONJUGATE, METHOD FOR PREPARATION THEREOF AND USE THEREOF IN MEDICINE | 2021 |
|
RU2830242C1 |
| CONJUGATE OF ANTI-CEA ANTIBODY AND EXCATECAN ANALOGUE AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2833323C1 |
| ANTI-CLAUDIN 18.2 ANTIBODY AND USE THEREOF | 2020 |
|
RU2822550C2 |
| ANTIBODY TO CD3 AND ITS PHARMACEUTICAL USE | 2019 |
|
RU2802272C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODY TO PD-L1 AND ITS APPLICATION | 2018 |
|
RU2766590C2 |
| ANTIBODY-DRUG CONJUGATE, INTERMEDIATE FOR ITS PRODUCTION, METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2800137C1 |
| ANTIBODY TO CD40, ITS ANTIGENE-BINDING FRAGMENT AND ITS MEDICAL USE | 2018 |
|
RU2779128C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE, AND USE THEREOF | 2021 |
|
RU2840147C1 |
| METHOD OF PRODUCING AN ANTIBODY-DRUG CONJUGATE | 2021 |
|
RU2841377C1 |
